Nath Bio-Genes (India) Share Price Target 2026 Analyst Forecast Bull and Bear Case

The Nath Bio-Genes (India) share price target stands at Rs 225 for 2026, implying approximately 34% upside from the current market price of Rs 168. The stock trades at a price-to-earnings ratio of 7.45x, reflecting attractive value versus sector peers, with a market capitalisation of Rs 310 Cr. Investors tracking the seeds & agri segment are closely watching Nath Bio-Genes (India) as an emerging opportunity given its 52-week range of Rs 126 to Rs 239. This analysis covers the bull case, bear case, and key catalysts that will define the Nath Bio-Genes (India) share price target trajectory through 2026.

Click Here – Get Free Investment Predictions

Nath Bio-Genes (India) Company Overview and Key Metrics

Nath Bio-Genes (India)	Details
NSE Symbol	NATHBIOGEN
Sector	Seeds & Agri
CMP (Rs)	168
52W High (Rs)	239
52W Low (Rs)	126
Market Cap (Rs Cr)	310 Cr
P/E Ratio	7.45
12M Target (Rs)	225
Bull Case (Rs)	260
Bear Case (Rs)	180

Nath Bio-Genes (India) is a seeds & agri company listed on the National Stock Exchange (NSE: NATHBIOGEN). With a market capitalisation of Rs 310 Cr, the company occupies a defined position in the Indian seeds & agri landscape. The stock has traded in a wide range over the past 12 months, touching a high of Rs 239 and a low of Rs 126, before arriving at its current level of Rs 168. Uniresearch analysts project a 12-month Nath Bio-Genes (India) share price target of Rs 225, with a bull case of Rs 260 and a bear case of Rs 180.

Why Is the Nath Bio-Genes (India) share price target Set at Rs 225 for 2026

FY27 Earnings Delivery and Revenue Acceleration

The Nath Bio-Genes (India) share price target of Rs 225 is anchored in expectations of FY27 earnings delivery. At a P/E of 7.45x on trailing earnings, the stock is attractively valued. Consistent revenue growth and margin improvement in coming quarters can re-rate the stock towards the Rs 225 target.

Strong Domestic Consumption and Growing Middle Class

India’s consumption story remains intact with GDP growth projected at 6.5-7% in FY27. A rising middle class with increasing discretionary spending is expanding the addressable market for companies across most sectors.

Favourable Policy Environment and Make in India Push

Government initiatives promoting domestic manufacturing through PLI schemes, import substitution, and ease of doing business reforms are structurally improving the operating environment for Indian companies.

RBI Rate Cut Cycle and Lower Cost of Capital

The Reserve Bank of India has shifted to an accommodative monetary policy stance, with rate cuts reducing borrowing costs across the economy. For Nath Bio-Genes (India), lower interest rates translate to reduced finance costs and potentially higher consumer demand in its end markets, creating a favourable backdrop for the Nath Bio-Genes (India) share price target to materialise by year-end.

Union Budget 2026 and Policy Tailwinds

The Union Budget 2026-27 has maintained strong capex allocation of Rs 11 lakh crore for infrastructure, directly benefiting sectors including seeds & agri. Tax rationalisation and sector-specific policy support create a constructive policy environment that supports the Nath Bio-Genes (India) share price target thesis through improved demand visibility.

Nath Bio-Genes (India) Share Price Target Short Term, 12 Month and Long Term

Short Term Nath Bio-Genes (India) Share Price Target: 3 to 6 Months

In the near term, the Nath Bio-Genes (India) share price target for the next 3 to 6 months is pegged at Rs 180, contingent on Q1 FY27 earnings meeting expectations and sustained buying interest in the seeds & agri segment. Technically, the stock needs to hold the Rs 132-139 zone for this short-term target to remain valid.

12 Month Nath Bio-Genes (India) Share Price Target 2026

Our 12-month Nath Bio-Genes (India) share price target is Rs 225. This target is based on the Uniresearch fundamental estimate, which factors in FY27 revenue growth, margin normalisation, and sector re-rating potential. The Rs 225 level represents approximately 34% upside from the current price of Rs 168.

Long Term Nath Bio-Genes (India) Share Price Target: FY27 to FY28

Over a 2 to 3 year horizon, the long-term Nath Bio-Genes (India) share price target is estimated between Rs 259 and Rs 304, assuming continued compounding in earnings, potential capacity expansions, and improved market positioning. Investors with a multi-year holding perspective may find the current CMP of Rs 168 an attractive accumulation level.

Bull Case and Bear Case for Nath Bio-Genes (India) Share Price Target

Bull Case: Rs 260

In the bull case scenario, Nath Bio-Genes (India) delivers above-estimate earnings growth driven by strong demand, margin expansion, and new business wins. If these catalysts materialise simultaneously, the Nath Bio-Genes (India) share price target could reach Rs 260, implying approximately 55% upside from the current market price.

Bear Case: Rs 180

The bear case of Rs 180 assumes earnings disappointment, sector-level de-rating, or broader market selloff driven by FII outflows. In this scenario, Nath Bio-Genes (India) could re-test support levels closer to its 52-week low of Rs 126, representing a downside risk investors should monitor.

Scenario	Target Price (Rs)	Upside/Downside from CMP	Key Assumption
Bull Case	260	55%	Strong earnings growth, sector re-rating
Base Case	225	34%	Steady earnings, margin improvement
Bear Case	180	7%	Earnings miss, macro headwinds

Key Risks to the Nath Bio-Genes (India) Share Price Target 2026

Macro Headwind from Global Slowdown and US Tariff Policy

A sharper-than-expected global slowdown or escalation in US-China trade tensions could dampen demand across sectors. Nath Bio-Genes (India) faces indirect risk if its customers or supply chain partners are impacted by slower global growth, as this could translate to lower order volumes or pricing pressure.

Valuation Risk and Earnings Miss Scenario

If Nath Bio-Genes (India) reports quarterly earnings below analyst estimates or provides weak forward guidance, the stock could see significant de-rating. Elevated valuations in some segments leave limited margin for error, making execution risk a critical near-term concern.

Competitive Pressure in the Seeds & Agri Segment

The seeds & agri space in India is increasingly competitive with both domestic players and global companies vying for market share. Price competition, product commoditisation, or loss of key client contracts could pressure Nath Bio-Genes (India)’s revenue trajectory.

FII Selling and Broader Market Volatility

Foreign Institutional Investor selling in Indian equities has historically led to broad-based price corrections even in fundamentally sound companies. Nath Bio-Genes (India)’s share price could face near-term pressure if FII sentiment turns risk-off due to global monetary policy changes.

How to Invest in Nath Bio-Genes (India) Stock

Step 1: Research and Fundamental Analysis. Before investing, thoroughly review Nath Bio-Genes (India)’s quarterly results, annual report, and management commentary. Focus on revenue growth trajectory, operating margin trends, and debt levels to assess whether the Nath Bio-Genes (India) share price target of Rs 225 is achievable.

Step 2: Use Stock Screeners for Live Data.

Check Nath Bio-Genes (India) Live Data on Univest Screener

Monitor key metrics including P/E, return on equity, and promoter holding changes. These ratios can confirm or challenge the Nath Bio-Genes (India) share price target thesis in real time.

Step 3: Define Your Entry Zone. The current CMP of Rs 168 is within the identified accumulation zone based on the 52-week low of Rs 126 and the Uniresearch target of Rs 225. Consider entering in tranches to average your cost over market fluctuations.

Step 4: Set Stop Loss and Risk Management Levels. Always define a stop-loss level before investing. A prudent stop-loss for Nath Bio-Genes (India) based on the current technical setup would be in the Rs 147 to Rs 154 range. Never risk more than 2-5% of your portfolio in any single position.

Step 5: Open a Zero-Brokerage Demat Account. To invest in Nath Bio-Genes (India) at zero brokerage, open your demat account with Univest, which combines SEBI-registered research with integrated trading. This allows you to act on the Nath Bio-Genes (India) share price target analysis without incurring unnecessary transaction costs.

Download the Univest iOS App or Univest Android App to track Nath Bio-Genes (India) live price and get daily stock recommendations.

Conclusion

The Nath Bio-Genes (India) share price target for 2026 is Rs 225, with a bull case of Rs 260 and a bear case of Rs 180, based on Uniresearch estimates as of 29 June 2026. At a CMP of Rs 168 with a 52-week range of Rs 126 to Rs 239, Nath Bio-Genes (India) presents a risk-reward opportunity that warrants monitoring. Investors should review Q1 FY27 results, track management commentary on guidance, and consult a SEBI-registered advisor before making investment decisions. The Nath Bio-Genes (India) share price target outlined here is for educational purposes only.

FAQs on Nath Bio-Genes (India) Share Price Target 2026

What is the Nath Bio-Genes (India) share price target for 2026?

Ans. The Nath Bio-Genes (India) share price target for 2026, as per Uniresearch estimate, is Rs 225. This implies approximately 34% upside from the current market price of Rs 168.

Is Nath Bio-Genes (India) a good stock to buy right now?

Ans. Whether Nath Bio-Genes (India) is a good buy depends on your investment horizon, risk appetite, and portfolio allocation. The Uniresearch Nath Bio-Genes (India) share price target of Rs 225 implies meaningful upside, but investors must assess company fundamentals and market conditions before investing.

What is Nath Bio-Genes (India)’s 52-week high and low?

Ans. Nath Bio-Genes (India)’s 52-week high is Rs 239 and the 52-week low is Rs 126, as of 29 June 2026. The current price of Rs 168 represents a 33% gain from the 52-week low.

What is the market cap of Nath Bio-Genes (India)?

Ans. The market capitalisation of Nath Bio-Genes (India) is approximately Rs 310 Cr, as of 29 June 2026.

What are the key risks to the Nath Bio-Genes (India) share price target?

Ans. Key risks to the Nath Bio-Genes (India) share price target of Rs 225 include earnings disappointment, global macro headwinds, FII selling pressure, and competitive intensity in the seeds & agri sector. Any of these factors could delay or reduce the target realisation.

What is the bull case target for Nath Bio-Genes (India) in 2026?

Ans. In the bull case scenario, the Nath Bio-Genes (India) share price target could reach Rs 260, implying approximately 55% upside from the current level. This assumes stronger-than-expected earnings growth and sector re-rating.

Where can I track Nath Bio-Genes (India) share price live?

Ans. You can track Nath Bio-Genes (India) (NSE: NATHBIOGEN) live price, charts, and fundamental data on the Univest app or screener. The Univest platform provides real-time price data, analyst research, and portfolio tracking in one place.

How do I invest in Nath Bio-Genes (India) stock?

Ans. To invest in Nath Bio-Genes (India), open a demat account with a SEBI-registered broker like Univest, which offers zero brokerage and integrated research. Search for the ticker NATHBIOGEN on NSE, review fundamentals using the Univest Screener, and invest based on your financial goals and risk profile.